Search Results - Desai, Ankit K.

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review

    Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review by Desai, Ankit K., Li, Cindy, Rosenberg, Amy S., Kishnani, Priya S.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy

    Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy by Desai, Ankit K., Kazi, Zoheb B., Bali, Deeksha S., Kishnani, Priya S.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort

    Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort by Desai, Ankit K., Baloh, Carolyn H., Sleasman, John W., Rosenberg, Amy S., Kishnani, Priya S.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    A favorable outcome in an infantile-onset Pompe patient with cross reactive immunological material (CRIM) negative disease with high dose enzyme replacement therapy and adjusted immunomodulation

    A favorable outcome in an infantile-onset Pompe patient with cross reactive immunological material (CRIM) negative disease with high dose enzyme replacement therapy and adjusted im... by Curelaru, Shiri, Desai, Ankit K., Fink, Daniel, Zehavi, Yoav, Kishnani, Priya S., Spiegel, Ronen

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation

    Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation by Desai, Ankit K., Walters, Crista K., Cope, Heidi L., Kazi, Zoheb B., DeArmey, Stephanie M., Kishnani, Priya S.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Pulmonary Outcome Measures in Long Term Survivors of Infantile Pompe Disease on Enzyme Replacement Therapy: A case series

    Pulmonary Outcome Measures in Long Term Survivors of Infantile Pompe Disease on Enzyme Replacement Therapy: A case series by ElMallah, Mai K., Desai, Ankit K., Nading, Erica Burner, DeArmey, Stephanie, Kravitz, Richard M., Kishnani, Priya S.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease

    A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease by Gupta, Punita, Shayota, Brian J., Desai, Ankit K., Kiblawi, Fuad, Myridakis, Dorothy, Messina, John, Tah, Peter, Tambini-King, Lorien, Kishnani, Priya S.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via Newborn Screening: The benefits of early treatment with enzyme replacement therapy and immune tolerance induction

    Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via Newborn Screening: The benefits of early treatment with enzyme replacement therapy and imm... by Li, Cindy, Desai, Ankit K., Gupta, Punita, Dempsey, Katherine, Bhambhani, Vikas, Hopkin, Robert J., Ficicioglu, Can, Tanpaiboon, Pranoot, Craigen, William J., Rosenberg, Amy S., Kishnani, Priya S.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G “late-onset” GAA variant

    Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G “late-onset” GAA variant by Rairikar, Mugdha V., Case, Laura E., Bailey, Lauren A., Kazi, Zoheb B., Desai, Ankit K., Berrier, Kathryn L., Coats, Julie, Gandy, Rachel, Quinones, Rebecca, Kishnani, Priya S.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

    Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease by De Groot, Anne S., Desai, Ankit K., Lelias, Sandra, Miah, S. M. Shahjahan, Terry, Frances E., Khan, Sundos, Li, Cindy, Yi, John S., Ardito, Matt, Martin, William D., Kishnani, Priya S.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Sustained immune tolerance induction in enzyme replacement therapy–treated CRIM-negative patients with infantile Pompe disease

    Sustained immune tolerance induction in enzyme replacement therapy–treated CRIM-negative patients with infantile Pompe disease by Kazi, Zoheb B., Desai, Ankit K., Berrier, Kathryn L., Troxler, R. Bradley, Wang, Raymond Y., Abdul-Rahman, Omar A., Tanpaiboon, Pranoot, Mendelsohn, Nancy J., Herskovitz, Eli, Kronn, David, Inbar-Feigenberg, Michal, Ward-Melver, Catherine, Polan, Michelle, Gupta, Punita, Rosenberg, Amy S., Kishnani, Priya S.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease

    An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe dise... by Kazi, Zoheb B., Desai, Ankit K., Troxler, R. Bradley, Kronn, David, Packman, Seymour, Sabbadini, Marta, Rizzo, William B., Scherer, Katalin, Abdul-Rahman, Omar, Tanpaiboon, Pranoot, Nampoothiri, Sheela, Gupta, Neerja, Feigenbaum, Annette, Niyazov, Dmitriy M., Langston, Sherry, Segel, Reeval, McVie-Wylie, Alison, Sung, Crystal, Joseph, Alexandra M., Richards, Susan, Kishnani, Priya S.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: